Innovations in Healthcare: From Treatment to Screening

This chapter explores the potential benefits of GLP-1 agonists like semaglutide and liraglutide for treating alcohol use disorder and obesity while addressing key concerns about their use. It also highlights the findings of the BALANCE trial on antibiotic duration in bloodstream infections and the evolving cervical cancer screening guidelines, including the rise of patient-collected HPV testing. The discussion emphasizes the importance of ongoing research and the shift toward self-collection methods in improving patient care and accessibility.